In some cases, medical professionals must carefully separate glued eyelashes or scrape adhesive from the surface of the eye.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...